Cite
MLA Citation
Akshata Udyavar et al.. “338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6).” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A206–A207. http://access.bl.uk/ark:/81055/vdc_100144717185.0x000006